Riskpilot← Back to searchSign inGet full accessSCIENCE LINKER AS
ASActiveOrg 990342539Tennisveien 55, 0777 OsloComputer programming activities · NACE 6210Est. 20061 employees
Revenue 2024
NOK 338K
-16% vs 2023
EBITDA margin
-1.8%
-110% vs 2023
Equity ratio
75.3%
Financial strength
Net profit 2024
NOK -3K
-109% vs 2023
| Revenue | NOK 338K | -16% |
| EBITDA | NOK -6K | -110% |
| Net profit | NOK -3K | -109% |
| Total assets | NOK 189K | -5% |
| Equity | NOK 142K | -2% |
| Employees | 1 | — |
Legal name
SCIENCE LINKER AS
Org number
990342539
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
11. oktober 2006
Share capital
NOK 102 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikling og salg av dataprogrammer, samt øvrig virksomhet og investeringer av enhver art.
Address
Tennisveien 55, 0777 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 242 | 314 | 313 | 403 | 338 |
| Staff expenses | −259 | −294 | −293 | −324 | −324 |
| EBITDA | −40 | 0 | −1 | 62 | −6 |
| Depreciation & amort. | −8 | −8 | −8 | −30 | −0 |
| EBIT | −48 | −8 | −9 | 31 | −6 |
| Net financials | 0 | 1 | 1 | 5 | 3 |
| Profit before tax | −48 | −7 | −7 | 36 | −3 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −48 | −7 | −7 | 36 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 159 | 316 | 314 | 198 | 189 |
| Equity | 124 | 117 | 110 | 146 | 142 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 34 | 199 | 204 | 52 | 47 |
| Total debt | 34 | 199 | 204 | 52 | 47 |
EBITDA margin
-1.8%
This company
15.8%
Market median
-111% vs market
20202024
Equity ratio
75.3%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20202024
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20202024
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KP Chief Executive Officer | Chief Executive Officer | 2014 |
| Former (1) | ||
JM Deputy Member | Deputy Member | 2007 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Neurotransporter As
SCIENCE LINKER AS Board members of SCIENCE LINKER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Petter Dæhlin Lehre | Chief Executive Officer | 0 companies |
| Jan Martin Fjellestad | Deputy Member | 0 companies |
| Niels Christian Danbolt | Chairman | 0 companies |